MNPR

$57.79

$

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubicin, an analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; MNPR-101, a urokinase plasminogen activator receptor targeted antibody for the treatment of various cancers; MNPR-101 RIT, a radioimmunotherapeutic based on MNPR-101 for the potential treatment of cancer and severe COVID-19; and MNPR-202, an analog of camsirubicin to potentially treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations with the Grupo Español de Investigación en Sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; NorthStar Medical Radioisotopes, LLC to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was incorporated in 2014 and is headquartered in Wilmette, Illinois.

Next Earnings

2026-02-25

Beta

1.568

Average Volume

Market Cap

Last Dividend

CIK

0001645469

ISIN

US61023L2079

CUSIP

61023L108

CEO

Chandler D. Robinson

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

14

IPO Date

2019-12-19

Status

Active

Latest News

Title Headline Publisher Date
What Awaits These 4 Biotech Stocks That More Than Doubled in 2025 IONS, GPCR, MNPR and KOD more than double in 2025 as policy clarity, M&A revival and clinical wins lift biotech momentum into 2026. Zacks Investment Research 2025-12-22 11:16:08

SEC Filings

Type Filing Date Accepted Date Link
SC 13G/A 2026-02-17 2026-02-17 View Filing
SC 13G/A 2026-02-06 2026-02-06 View Filing
SC 13D/A 2026-01-30 2026-01-30 View Filing
4 2026-01-30 2026-01-30 View Filing
4 2026-01-05 2026-01-05 View Filing
4 2026-01-05 2026-01-05 View Filing
4 2026-01-05 2026-01-05 View Filing
4 2025-12-29 2025-12-29 View Filing
4 2025-12-19 2025-12-19 View Filing
4 2025-12-17 2025-12-17 View Filing
4 2025-12-17 2025-12-17 View Filing
4 2025-12-08 2025-12-08 View Filing
4 2025-12-08 2025-12-08 View Filing
4 2025-12-08 2025-12-08 View Filing
4 2025-12-08 2025-12-08 View Filing
4 2025-12-08 2025-12-08 View Filing
4 2025-12-08 2025-12-08 View Filing
4 2025-12-08 2025-12-08 View Filing
4 2025-12-08 2025-12-08 View Filing
SC 13G/A 2025-11-14 2025-11-14 View Filing
SC 13G/A 2025-11-14 2025-11-14 View Filing
8-K 2025-11-13 2025-11-13 View Filing
10-Q 2025-11-13 2025-11-13 View Filing
8-K 2025-11-10 2025-11-10 View Filing
4 2025-10-02 2025-10-02 View Filing
4 2025-10-02 2025-10-02 View Filing
4 2025-09-26 2025-09-26 View Filing
SC 13D/A 2025-09-24 2025-09-24 View Filing
8-K 2025-09-24 2025-09-24 View Filing
424B5 2025-09-24 2025-09-24 View Filing
8-K 2025-09-15 2025-09-15 View Filing
EFFECT 2025-09-10 2025-09-10 View Filing
S-3 2025-08-29 2025-08-29 View Filing
SC 13G/A 2025-08-14 2025-08-14 View Filing
8-K 2025-08-12 2025-08-12 View Filing
10-Q 2025-08-12 2025-08-12 View Filing
4 2025-07-16 2025-07-16 View Filing
4 2025-07-16 2025-07-16 View Filing
4 2025-07-16 2025-07-16 View Filing
4 2025-07-02 2025-07-02 View Filing
4 2025-07-02 2025-07-02 View Filing
8-K 2025-06-23 2025-06-20 View Filing
DEFA14A 2025-05-23 2025-05-23 View Filing
SC 13G/A 2025-05-14 2025-05-14 View Filing
10-Q 2025-05-13 2025-05-13 View Filing
8-K 2025-05-13 2025-05-13 View Filing
ARS 2025-05-12 2025-05-09 View Filing
8-K 2025-05-07 2025-05-07 View Filing
DEF 14A 2025-04-30 2025-04-30 View Filing
4 2025-04-04 2025-04-04 View Filing
4 2025-04-02 2025-04-02 View Filing
4 2025-04-02 2025-04-02 View Filing
8-K 2025-03-31 2025-03-31 View Filing
S-8 2025-03-31 2025-03-31 View Filing
10-K 2025-03-31 2025-03-31 View Filing
4 2025-03-07 2025-03-07 View Filing
4 2025-03-07 2025-03-07 View Filing
4 2025-03-07 2025-03-07 View Filing
4 2025-03-07 2025-03-07 View Filing
4 2025-03-07 2025-03-07 View Filing
4 2025-03-07 2025-03-07 View Filing
4 2025-03-07 2025-03-07 View Filing
3 2025-03-06 2025-03-06 View Filing
4 2025-03-05 2025-03-05 View Filing
3 2025-03-05 2025-03-05 View Filing
8-K 2025-03-03 2025-03-03 View Filing
8-K 2025-02-24 2025-02-24 View Filing
SC 13G/A 2025-02-14 2025-02-14 View Filing
SC 13G/A 2025-02-14 2025-02-14 View Filing
SC 13G 2025-02-12 2025-02-12 View Filing
SC 13D/A 2025-02-07 2025-02-07 View Filing
EFFECT 2025-01-28 2025-01-28 View Filing
424B3 2025-01-27 2025-01-27 View Filing
S-3 2025-01-15 2025-01-15 View Filing
SC 13G/A 2025-01-08 2025-01-08 View Filing
4 2025-01-02 2025-01-02 View Filing
4 2025-01-02 2025-01-02 View Filing
4 2025-01-02 2025-01-02 View Filing
8-K 2024-12-23 2024-12-23 View Filing
424B5 2024-12-23 2024-12-23 View Filing
424B3 2024-12-18 2024-12-18 View Filing
EFFECT 2024-12-18 2024-12-18 View Filing
SC 13D/A 2024-12-17 2024-12-17 View Filing
4 2024-12-17 2024-12-17 View Filing
8-K 2024-12-06 2024-12-06 View Filing
S-3 2024-11-29 2024-11-29 View Filing
8-K 2024-11-08 2024-11-08 View Filing
10-Q 2024-11-08 2024-11-08 View Filing
SC 13G 2024-11-06 2024-11-06 View Filing
SC 13G 2024-10-31 2024-10-31 View Filing
4 2024-10-30 2024-10-30 View Filing
8-K 2024-10-30 2024-10-30 View Filing
424B5 2024-10-29 2024-10-29 View Filing
424B5 2024-10-28 2024-10-28 View Filing
SC 13G 2024-10-28 2024-10-28 View Filing
SC 13G 2024-10-24 2024-10-24 View Filing
8-K 2024-10-24 2024-10-24 View Filing
8-K 2024-10-22 2024-10-22 View Filing
8-K 2024-10-15 2024-10-15 View Filing
8-K 2024-10-07 2024-10-07 View Filing

Algorithm Performance

Upgrade To Premium for Full Access
Algorithm Profit/Loss Profit Factor # Trades Sharpe Sortino Efficiency
Adaptive Wave 53.22% 1 1 1.31 1.22 23.49
Heikin Ashi Strategy 45.80% 1.31 7 1.16 1.08 16.06
Volume Weighted Momentum Strategy 35.29% 1 1 2.51 0 42.01
xxxxxxxxxxxxxxxxxxxx xxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx x
xxxxxxxxxxxxxxxxxxxx xxxxx% xxxx x xxxx xxx xxxxx
xxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxx xxxxxxx% xxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxx xxxxx
xxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxx xxxxx
xxxxxxxxxxxxxxxx xxxxxxx% x x xxxx xxxx xxxxx
xxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxx xxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxxx
xxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxx xxxxx
xxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxx xxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxx xxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxx xxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxx xxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxx x% x xx x x xxxx
xxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxx% x x xxxxx xxxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx x x xxxx
xxxx xxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxx xxxxxxx% xxxx x xxxxx xxxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xx xxxxx xxxxx x
xxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxx
xxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx x x xxxx
xxxxxxxxxxxx xxxxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxx xxxxxxxx% xxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxx xxxxxxxx% xxx x xxxx xxxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxx x xxxxx xxxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxx x xxxx xxxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxx xxxxxxxx% x xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxx xxxxxxxx% x xx xxxxx xxxxx xxxx
xxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxx
xxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx x
xxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxxx
xxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx